Newsletters

Novartis AG and Another v Ranbaxy (Malaysia) Sdn. Bhd.

In the case of Novartis AG and Another v Ranbaxy (Malaysia) Sdn. Bhd. [2013] 2 SLR 117, the plaintiff was the proprietor of a Singapore patent and the defendant sought to import a pharmaceutical product which related to the plaintiff’s…

Exceptions to Loss of Novelty for Malaysian Patents

Malaysian patent law has a worldwide novelty standard, qualified by a 12-month grace period. Section 14(3) of the Malaysian Patents Act stipulates that this grace period is available to a patent applicant in respect of disclosures that are by reason…

Code of Good Conduct For Malaysian IP Agents

Effective 01 January 2014, the Malaysian Intellectual Property Office (“MyIPO”) has released a set of guidelines for the good conduct of IP Agents. Its main purpose and objective is to introduce and put in place a set of rules to…

Top 10 PCT filers in 2013

According to WIPO, there were about 205,300 PCT applications filed in 2013. This represents an increase of 5.1% over 2012. The top 10 filing countries are: Download